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IQ motif-containing GTPase activating protein 1 (IQGAP1)
plays a central role in the physical assembly of relevant signaling
networks that are responsible for various cellular processes,
including cell adhesion, polarity, and transmigration. The RHO
family proteins CDC42 and RAC1 have been shown to mainly
interact with the GAP-related domain (GRD) of IQGAP1. How-
ever, the role of its RASGAPC-terminal (RGCT) andC-terminal
domains in the interactions with RHO proteins has remained
obscure. Here, we demonstrate that IQGAP1 interactions with
RHOproteins underlie amultiple-step bindingmechanism: (i) a
high affinity, GTP-dependent binding of RGCT to the switch
regions of CDC42 or RAC1 and (ii) a very low affinity binding of
GRD and a C terminus adjacent to the switch regions. These
data were confirmed by phosphomimetic mutation of serine
1443 to glutamate within RGCT, which led to a significant
reduction of IQGAP1 affinity for CDC42 and RAC1, clearly dis-
closing the critical role of RGCT for these interactions. Unlike
CDC42, an extremely low affinitywas determined for theRAC1-
GRD interaction, suggesting that the molecular nature of
IQGAP1 interaction with CDC42 partially differs from that of
RAC1. Our study provides new insights into the interaction
characteristics of IQGAP1 with RHO family proteins and high-
lights the complementary importance of kinetic and equilib-
rium analyses. We propose that the ability of IQGAP1 to inter-
act with RHO proteins is based on a multiple-step binding
process, which is a prerequisite for the dynamic functions of
IQGAP1 as a scaffolding protein and a critical mechanism in
temporal regulation and integration of IQGAP1-mediated cel-
lular responses.
The RHO family proteins are critical regulators of many
diverse cellular functions (1). They share two common func-
tional characteristics, potential membrane anchorage, and an
on/off switch cycle (2). RHO protein function is dependent on
the guanine nucleotide binding (G) domain that contains the
principal GDP/GTP binding pocket and presents, depending
on its nucleotide-bound state, various contact sites for regula-
tors and effectors (2). Membrane-associated RHO proteins act,
with some exceptions (3), as molecular switches by cycling
between an inactive GDP-bound state and an active GTP-
bound state. This cycle underlies two critical intrinsic reac-
tions, the GDP/GTP exchange and GTP hydrolysis (3), and is
controlled by threemain classes of regulatory proteins (2), gua-
nine nucleotide dissociation inhibitors (GDIs)3 (4), guanine
nucleotide exchange factors (GEFs) (5), and GTPase activating
proteins (GAPs) (6). The formation of the active, GTP-bound
state of RHO proteins is accompanied by a conformational
change in two regions known as switch I and II (2). These
regions provide a platform for the selective interaction with
structurally and functionally diverse effectors (2, 7, 8), e.g. p21-
activated kinase 1 (PAK1) (9), Wiskott-Aldrich syndrome pro-
teins (WASP) (10), p67phox, a member of the NADPH oxidase
family (11), and semaphorin receptor Plexin B1 (12, 13) as well
as the IQ motif-containing GTPase activating proteins
(IQGAPs) (14, 15).
IQGAP1 is a ubiquitously expressed scaffold protein in-
volved in a variety of cellular processes, such as cell motility,
cell-cell adhesion, protein trafficking, transcription, neoplasia,
and microbial pathogenesis (14–17). A prerequisite to achieve
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these functions is association of a multitude of signaling mole-
cules, e.g. calmodulin, kinases, andGTPases such asCDC42 and
RAC1 (18–21). Distinct domains of IQGAP1, include anN-ter-
minal calponin homology domain (CHD), a coiled-coil repeat
region (CC), a tryptophan-containing proline-rich motif-bind-
ing region (WW), four isoleucine/glutamine-containing motifs
(IQ), a RAS GAP-related domain (GRD), a RASGAP C-termi-
nal domain (RGCT), and an extreme C-terminal domain (CT)
(Fig. 1).
Work from several laboratories has shown that the C-termi-
nal half of IQGAP1, encompassing GRD, RGCT, and CT, binds
preferentially to the active, GTP-bound form of CDC42 (22–
25) (see also Table 1). IQGAP1 GRD, which is structurally a
RASGAP homologue but functionally an inactive RASGAP
(26), has very recently been demonstrated to undergo interac-
tion with CDC42 although with a substantially lower affinity
than the larger protein fragment, containing GRD, RGCT, and
CT (25, 26). These works together with homology modeling
using RHOA-RHOGAP (27), CDC42-RHOGAP (28), and
HRAS-RASGAP (29) complex structures provided structural
models of IQGAP1 GRD that contacts the switch regions of
active CDC42 (25, 26, 30). Remarkably, this model has been
very recently confirmed by a dimericGRD structure in complex
with four molecules of the constitutive active CDC42Q61L var-
iant (31). Interestingly, RGCT contains two serines, 1441 and
1443, that have been shown to be phosphorylation sites by pro-
tein kinaseC (PKC) (32). Phosphomimeticmutations at these
sites have been shown to significantly impair IQGAP1 interac-
tion with CDC42 (24). This strongly indicates that regions or
domains adjacent to theGRDare also critical for the interaction
with the RHO family proteins.
To shed more light on a structure-function relationship
of IQGAP1 interaction with CDC42 and RAC1, we purified
different IQGAP1 variants (Fig. 1 and Table 1) and compre-
hensively investigated these interactions using both a time-
resolved fluorescence stopped-flow spectrometry and fluo-
rescence polarization under equilibrium condition using two
different fluorescent reporters. The data provide unprece-
dented and novelmechanistic insights into the bindingmode of
IQGAP1 to RHO proteins and suggest a central role of the
RGCT for IQGAP1 binding to the CDC42 and RAC1.
Results
Kinetics of the IQGAP1 Interaction with CDC42 and RAC1—
Previous work has established that RHO proteins in complex
with methylanthraniloyl (mant or m)-conjugated GppNHp
(mGppNHp), a fluorescent and non-hydrolysable GTP analog
(Fig. 2A), shows a change in fluorescence upon association with
their downstream effectors using stopped-flow fluorometry
(10). This signal can be used to monitor the kinetics of the
effector interactions with RHO proteins. Thus, using stopped-
flow fluorometry (Fig. 2B), we examined whether such a signal
can be generated upon the interaction of IQGAP1 with RHO
proteins (see “Experimental Procedures”).We observed a rapid
change in fluorescence after mixing the GRD1-CT (comprising
the C-terminal half of IQGAP1; Fig. 1) with mGppNHp-bound
RAC1 (Fig. 2C) or CDC42 (Fig. 2D), which is directly related to
the association reaction (see below). There was no change in
fluorescence when RHOA-mGppNHp was mixed with
GRD1-CT (Fig. 2C), clearly showing that RHOA, in contrast to
CDC42 and RAC1, does not associate directly with IQGAP1
under these experimental conditions.
Interestingly, GRD1-CT binding to RAC1-mGppNHp re-
sulted in an increase in fluorescence (Fig. 2C), whereas associ-
ation with CDC42-mGppNHp led to a fluorescence decay (Fig.
2D). This indicates that CDC42 and RAC1, despite their high
sequence identity (71%), obviously differ in regard to their bind-
ing modes with IQGAP1. Consistent with our results Owen et
al. (25) have studiedGRD1-CT interaction with a large panel of
CDC42 andRAC1 variants and have suggested that CDC42 and
RAC1 appear to have partially overlapping binding sites for
IQGAP1 and may use different structural determinants to
achieve high affinity binding. To examine this issue we per-
formed competition experiments by mixing GRD1-CT with
FIGURE 1. Schematic representation of domain organization, various constructs, and proteins of IQGAP1. Shown is IQGAP1 domain organization along
with the PKC phosphorylation sites Ser-1441 and Ser-1443, constructs, and proteins relevant to this study. Coomassie Brilliant Blue (CBB)-stained SDS-PAGE
(12.5%) of purified IQGAP1 proteins used in this study is shown. CHD, calponin homology domain; CC, coiled-coil repeat region; WW, tryptophan-containing
proline-rich motif-binding region; IQ, four isoleucine/glutamine-containing motifs.
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fluorescent RAC1-mGppNHp and an excess of non-fluores-
cent CDC42-GppNHp under otherwise the same conditions as
above. Fig. 2E shows that the presence of CDC42-GppNHp
completely blocked GRD1-CT association with RAC1-mGp-
pNHp. A reverse experiment, mixing GRD1-CT with fluores-
cent CDC42-mGppNHp and an excess of non-fluorescent
RAC1-GppNHp, led to the same results (Fig. 2F). These data
indicated that CDC42 and RAC1, despite obvious differences,
share an overlapping binding region for GRD1-CT.
Control experiments using mGDP-bound, inactive CDC42
and RAC1 proteins showed no change in fluorescence when
they were mixed with GRD1-CT (Fig. 2, C and D). This result
supports previous observations (30, 33, 34) and indicates that
IQGAP1 primarily recognizes the switch regions of CDC42 and
RAC1 by preferentially binding to their GTP-bound, active
state. To investigate the IQGAP1-RHO protein interaction
characteristics in more details, we purified two different GRD
fragments designated as GRD1 and GRD2 (Fig. 1) and analyzed
their association with mGppNHp-bound RAC1 or CDC42. In
contrast to the GRD1-CT, none of these fragments remarkably
show any change in the fluorescence signal (Fig. 2, C and D),
even the highest actual concentration used for GRD1 and
GRD2 (data not shown). One possible reasonmay be the small-
sized “mant” as fluorescence reporter group (Fig. 2A). To exam-
ine this, we repeated the experiments under the same condi-
tions by using tetramethylrhodamine (also called “tamra”), a
different andmuch larger fluorescent reporter conjugated with
GppNHp (tGppNHp; supplemental Fig. S2A). Data obtained
with CDC42-tGppNHp clearly showed no GRD2 association
signal (supplemental Fig. S2B). This result was unexpected
because GRD is generally accepted as the RAC1 and CDC42
binding domain of IQGAP1 (24–26, 30). Our data suggest that
GRDeither does not directly interact withCDC42 andRAC1or
it associates outside the switch regions in a distant site from the
fluorescent mant and tamramoieties of the nucleotide, thereby
generating no change in the fluorescence signal.
IQGAP1 Possesses at Least Two CDC42 Binding Domains—
The next question addressed was whether IQGAP1 GRD can
physically associate with parts of CDC42 and RAC1 other than
their switch regions. We applied fluorescence polarization, a
different approach to determine the binding affinity of the two
proteins at equilibrium (Fig. 3A), andmeasured the dissociation
constant (Kd) of their interaction (35). Fig. 3,B andC, show that
titration of mGppNHp-bound CDC42 and RAC1 with increas-
ing amounts of not only GRD1-CT but, remarkably, also GRD2
led to an increase of polarization. These IQGAP1 domains,
however, did not exhibit any association with RHOA-mGp-
pNHp (Fig. 3,B andC).Kd values obtained from thesemeasure-
ments showed that GRD1-CT is a high affinity binder as com-
pared withGRD2, which shows 9- and 15-fold lower affinity for
mGppNHp-bound CDC42 and RAC1, respectively (Fig. 3C;
Table 1).
The explanation for our observations regarding interaction
of GRDwith the active form of RAC1 is simple; in direct mode,
FIGURE 2. GRD1-CT but not GRD selectively associates only with mGppNHp-bound, active RAC1 and CDC42. A, chemical structure of mGppNHp, a
fluorescently labeled, non-hydrolyzable GTP analog, used in this study. B, the stopped-flow device. The stopped-flow device consists of two motorized,
thermostated syringes, a mixing chamber, and a fluorescence detector. Two different protein solutions indicated in brackets were rapidly mixed and trans-
ferred to a fluorescence detection cell within4 ms. mGppNHp- or mGDP-bound RHO proteins were used in this study as the fluorescent reporter groups. C
and D, association of GRD1-CT with active, mGppNHp-bound CDC42 and RAC1. Kinetics of association were followed by rapidly mixing 2M GRD1-CT, GRD1,
or GRD2with 0.2MmGppNHp- ormGDP-boundRAC1 (C) or CDC42 (D). The obtained data are the average of four to six independentmeasurements. The kobs
values obtained for the association of GRD1-CT withmGppNHp-bound CDC42 and RAC1were 1.68 and 1.80 s1, respectively. No change in fluorescence was
observed for GRD1-CT- and mGDP-bound RAC1 or CDC42 (black), GRD1 or GRD2 with mGppNHp-bound RAC1 or CDC42 (red), and GRD1-CT with RHOA-
mGppNHp (blue). E and F, overlapping binding sites of CDC42 and RAC1 for GRD1-CT. Association of RAC1-mGppNHp (0.2 M) with GRD1-CT (2 M) was
blocked in the presence of excess amount of non-fluorescent CDC42-GppNHp (10M) (E). Association of CDC42-mGppNHp (0.2M) with GRD1-CT (2M) was
blocked in the presence of excess amount of non-fluorescent RAC1-GppNHp (10 M) (F).
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only a change in fluorescence can be observed when the asso-
ciating protein (e.g. GRD1-CT) binds in close vicinity of the
fluorophore (mant moiety of the bound mGppNHp or tamra
moiety of the bound tGppNHp) on the surface of CDC42 and
RAC1 (Figs. 2 and supplemental Fig. S2). This surface area of
RHO proteins covers the switch regions that change their con-
formation upon aGDP/GTPexchange (2). This is of fundamen-
tal importance because effectors (such as IQGAP1) first bind to
the switch regions, which represent the recognition sites. Bind-
ing of other additional effector domains determines the speci-
ficity of the interaction, which is ultimately required for effector
activation (2, 10, 36). So far our data suggest that the binding of
the GRD domain to RHO proteins seems to happen outside the
switch regions and, thus, would be expected to be independent
of the nucleotide status of the RHO protein. To prove this idea,
we repeated the measurements by using mGDP-bound, inac-
tive RHO proteins. Both GRD1-CT and GRD2 were able to
interact with mGDP-bound CDC42, although with very low
affinities but, surprisingly, not with RAC1 (Fig. 3, D and E;
Table 1); the latter was also the case for RHOA. This strongly
suggests that the molecular nature of IQGAP1 interaction with
CDC42 partially differs from that with RAC1, particularly with
regard to the role of GRD.We propose that IQGAP1 harbors at
least two distinct binding domains. RGCT contributes to a
high affinity binding to the switch regions of the GTP-
bound, active CDC42 and RAC1. GRD more selectively rec-
ognizes active forms of CDC42 and RAC1 but also binds to
other regions outside of the switch regions of CDC42, obvi-
ously in a nucleotide-independent manner.
RGCT Is Primarily Critical for the IQGAP1 Association with
CDC42 and RAC1—To further prove the critical role of the
C-terminal domains of IQGAP1 beyond GRD, we generated
various deletion and point mutations of IQGAP1 (Fig. 1). We
measured the effect of the last 99 amino acids of IQGAP1 on
CDC42 and RAC1 binding by using purified CT and GRD1-
RGCT (IQGAP1877–1558), which lacks this region (Fig. 1). In
contrast to GRD1-RGCT, isolated CT itself did not show, sim-
ilarly to GRD1 and GRD2, any change in fluorescence upon
mixing it with CDC42 and RAC1, respectively (Figs. 2,C andD,
and 4A). For comparison, the kobs values were obtained by fit-
ting all the data as single exponentials and are plotted as bar
charts, which illustrates that interaction of GRD1-RGCT with
CDC42 and RAC1 has different kobs compare with GRD1-CT
(Fig. 4B). These data emphasize the essential role of RGCT for
direct association of IQGAP1with the switch regions ofCDC42
and RAC1. We were able to purify RGCT (aa 1276–1575) and
also GST-fused RGCT-CT (aa 1276–1657) (Fig. 1). Both pro-
teins, however, tend to strongly oligomerize and elute in void
volume (supplemental Fig. S1B) such that we were unable to
test binding to CDC42 and RAC1 (data not shown).
Interestingly, RGCT contains two PKC phosphorylation
sites (Ser-1441 and Ser-1443; Fig. 1) (24, 32), which differently
affect GRD1-RGCT association with RAC1-mGppNHp upon
their phosphomimetic mutations. To investigate the effect of
IQGAP1 phosphorylation on the interaction with RAC1 and
CDC42 in more detail, we generated and purified phosphomi-
metic mutants of the GRD1-RGCTWT domain (GRD1-
RGCTS1441E and GRD1-RGCTS1443E).
FIGURE 3. IQGAP1 GRD binds CDC42 but not RAC1 in a nucleotide-independent manner. A, fluorescence polarization assay. Fluorescence polarization
signal of a fast tumbling fluorescent molecule, e.g. RAC1-mGppNHp in its unbound state, increased if a larger protein, e.g. IQGAP1, bound to it and formed a
slow tumbling complex. B, fluorescence polarization experiments were conducted by titrating mGppNHp-bound, active forms of CDC42, RAC1, and RHOA (1
M, respectively)with increasing concentrations of GRD1-CT (0–20M) orGRD2 (0–120M), respectively.C, evaluateddissociation constant (Kd) shownasbars
illustrates a significant difference in the binding properties of these two IQGAP1 proteins measured in B. D, fluorescence polarization experiments were
conducted under the same conditions as in B using mGDP-bound, inactive forms of CDC42, RAC1, and RHOA. E, calculated Kd values shown as bars clearly
indicated interaction of GRD1-CT and GRD2 with CDC42-mGDP but not with RAC1 and RHOA. Data are expressed as the mean S.D. All experiments were
performed in duplicate.
New IQGAP BindingMode for CDC42 and RAC1
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In contrast toGRD1-RGCTWT andGRD1-RGCTS1441E, with
Ser-1441 substituted byGlu, GRD1-RGCTS1443E with Ser-1443
substituted byGlu impaired the observed association of GRD1-
RGCT with active CDC42 and RAC1 (Fig. 4, A and B). Deter-
mination of the Kd values for the RAC1 and CDC42 binding
GRD1-RGCT variants using fluorescence polarization showed
that GRD1-RGCT and GRD1-RGCTS1441E exhibited binding
affinities for RAC1 and CDC42 in a similar range, which signif-
icantly differs from GRD1-RGCTS1443E (Fig. 4, C–E; Table 1).
These data suggest that RGCT is a critical domain in IQGAP1
that is primarily responsible for the recognition of switch
regions and association with the GTP-bound CDC42 and
RAC1. In addition, Ser-1443 phosphorylation appears to serve
as a regulatory switch for these interactions.Our data are in line
with the study of Elliott et al. (24) and support the previous
study by Li et al. (32), which highlighted the importance of this
phosphorylation event in IQGAP1-mediated cellular signaling.
To prove that these IQGAP1 variants, including GRD1-
RGCTS1443E, are structurally intact, we conducted circular
dichroism (CD) and analytical size exclusion chromatography
(SEC) analyses, respectively (supplemental Fig. S1). The CD
measurements demonstrate that all IQGAP1 variants used in
this study were well structured and did not reveal any signifi-
cant differences in the secondary structure between them. In
addition, SEC data revealed that the IQGAP1 variants are prop-
erly folded and exist as dimeric proteins as seen for GRD1-
RGCT and GRD2 (supplemental Fig. S1). The latter is in agree-
ment with the dimeric GRD structure in complex with
CDC42Q61L (31).
Modulatory Effects of CTon IQGAP1 InteractionwithCDC42
and RAC1—To understand the IQGAP1 interaction with
CDC42 and RAC1 in more details, kinetic measurements were
performed. This allowed us to obtain individual rate constants
kon and koff for the rate of association and dissociation, respec-
tively, as well as the dissociation constant (Kd) calculated from
the ratio of koff/kon. To calculate the kon value, association of
mGppNHp-bound RAC1 and CDC42 with increasing concen-
trations of GRD1-CTwasmeasured, leading to changes in fluo-
rescence curves characterized by individual kobs values (Fig. 5,A
and B, left panels). Obtained kobs values were fitted in a linear
fashion as a function of GRD1-CT concentrations, and the
slope of the fitted line provided the kon (Fig. 5, A and B,middle
panels). Displacement of GRD1-CT from fluorescently labeled
RAC1 and CDC42wasmeasured bymixing the RAC1/CDC42-
mGppNHp-GRD1-CT complex with an excess amount of non-
fluorescent RAC1/CDC42-GppNHp. Fig. 5,A and B, right pan-
els, shows a mono-exponential fluorescence decay for RAC1
and increase for CDC42 yielding the koff value for RAC1 and
CDC42, respectively. From the ratio of koff/kon, we calculated
the dissociation constant (Kd) of 0.94 and 0.30M for RAC1 and
CDC42, respectively, which is comparable with the values
obtained by fluorescence polarization in this study and other
methods in other laboratories (Table 1; Fig. 5C) (23, 25, 26). To
further confirm our obtained results with mGppNHp, CDC42
was loaded with larger fluorescent nucleotide tGppNHp (sup-
plemental Fig. S2 A and Fig. 2A). Kinetic data obtained for the
interaction of CDC42-tGppNHp with GRD1-CT, GRD1-
RGCT, and GRD1-RGCTS1443E were very similar to the data
TABLE 1
Data summary for the interaction of RHO proteins with IQGAP1
variants
The binding affinity of the IQGAP1 proteins for various RHO proteins has been
analyzed in different ways including the following: SFF, stopped-flow fluorometry;
FA, fluorescence assay; FP, fluorescence polarization; ITC, isothermal titration cal-
orimetry; PRA, phosphate-release assay; SPA, scintillation proximity assay; SPR,
surface plasmon resonance. n.s.o., no (fluorescence) signal observed; n.b.o., no bind-
ing observed.
IQGAP1 proteins Kda Method Reference
M
GRD1/RAC1-mGppNHp n.s.o. SFF This study
GRD1/CDC42-mGppNHp n.s.o. SFF This study
GRD2/RAC1-mGppNHp n.s.o. SFF This study
GRD2/CDC42-mGppNHp n.s.o. SFF This study
GRD2/CDC42-tGppNHp n.s.o. SFF This study
GRD2/CDC42Q61L-tGppNHp n.s.o. SFF This study
GRD1-CT/RAC1-mGppNHp 0.94 SFF This study
GRD1-CT/RAC1-mGDP n.s.o. SFF This study
GRD1-CT/CDC42-mGppNHp 0.30 SFF This study
GRD1-CT/CDC42-tGppNHp 0.38 SFF This study
GRD1-CT/CDC42Q61L-tGppNHp 0.05 SFF This study
GRD1-CT/CDC42-mGDP n.s.o. SFF This study
GRD1-CT/RHOA-mGppNHp n.s.o. SFF This study
GRD1-RGCTWT/RAC1-mGppNHp 2.81 SFF This study
GRD1-RGCTWT/CDC42-mGppNHp 2.72 SFF This study
GRD1-RGCTWT/CDC42-tGppNHp 1.45 SFF This study
GRD1-RGCTS1441E/RAC1-mGppNHp 3.21 SFF This study
GRD1-RGCTS1441E/CDC42-mGppNHp 2.05 SFF This study
GRD1-RGCTS1443E/RAC1-mGppNHp 6.26 SFF This study
GRD1-RGCTS1443E/CDC42-mGppNHp 7.03 SFF This study
GRD1-RGCTS1443E/CDC42-tGppNHp 4.19 SFF This study
CT/RAC1-mGppNHp n.s.o. SFF This study
CT/CDC42-mGppNHp n.s.o. SFF This study
GRD1-RGCT/CDC42-GDP 1.30 SPR (24)
GRD1-RGCTS1443D/CDC42-GDP 0.81 SPR (24)
GRD1-RGCTS1441E/CDC42-GDP 220.0 SPR (24)
IQGAP1 proteins eKdb Method Reference
M
GRD2/RAC1-mGppNHp 81.50 FP This study
GRD2/RAC1-mGDP n.b.o FP This study
GRD2/CDC42-mGDP 185 FP This study
GRD2/CDC42-mGppNHp 30.20 FP This study
GRD2/CDC42Q61L-mGppNHp 2.37 FP This study
GRD2/CDC42Q61L-tGppNHp 1.13 FP This study
GRD2/RHOA-mGppNHp n.b.o. FP This study
GRD1-CT/RAC1-mGppNHp 5.53 FP This study
GRD1-CT/CDC42-mGDP 95.10 FP This study
GRD1-CT/CDC42-mGppNHp 3.40 FP This study
GRD1-CT/CDC42Q61L-mGppNHp 0.83 FP This study
GRD1-CT/CDC42Q61L-tGppNHp 0.52 FP This study
GRD1-CT/RHOA-mGppNHp n.b.o. FP This study
GRD1-RGCTWT/RAC1-mGppNHp 4.60 FP This study
GRD1-RGCTS1441E/RAC1-mGppNHp 6.70 FP This study
GRD1-RGCTS1443E/RAC1-mGppNHp 26.70 FP This study
GRD1-RGCTWT/CDC42-mGppNHp 4.60 FP This study
GRD1-RGCTS1441E/CDC42-mGppNHp 3.60 FP This study
GRD1-RGCTS1443E/CDC42-mGppNHp 16.30 FP This study
GRD1-CT/CDC42-mdGTP 0.028 FA (47)
GRD1-CT/RAC1Q61L-[3H]GTP 0.018 SPA (25)
GRD2c/RAC1Q61L-[3H]GTP n.b.o. SPA (25)
GRD1-CT/CDC42Q61L-[3H]GTP 0.024 SPA (25)
GRD2c/CDC42Q61L-[3H]GTP 0.14 SPA (25)
GRD2/CDC42Q61L-GTP 1.30 ITC (26)
GRD2/CDC42Q61L 0.1 ITC (31)
GRD2/CDC42-GDP n.b.o. ITC (26)
IQGAP1 proteins Kic Method Reference
M
GRD1-CT/CDC42Q61L-GTP 0.082 PRA (76)
GRD1-CT/CDC42-GTP 0.39 PRA (23)
GRD1-CT/RAC1-GTP 2.13 PRA (23)
a Kinetic conditions provide individual association and dissociation rate constants
(kon and koff) and determine the dissociation constants (Kd).
b Equilibrium conditions determine the equilibrium dissociation constants (eKd).
c Encompasses amino acids 950–1407.
d Competitive reaction conditions; for example, inhibition of the intrinsic GTP
hydrolysis reaction of the RHO proteins, which determines the equilibrium inhi-
bition constant (Ki).
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described above for CDC42-mGppNHp (supplemental Fig. S2
and Fig. 5A).
CDC42 as compared with RAC1 exhibited a faster kon, a
slower koff, and therefore, a 3-fold higher binding affinity for
GRD1-CT (Fig. 5, B andC). GRD1-RGCT, lacking the C-termi-
nal CT domain, strikingly revealed a 4–6-fold faster koff in
comparison to GRD1-CT, whereas the kon values remained
largely the same (Figs. 5C, supplemental Figs. S3 and S4). Thus,
C-terminal truncation of IQGAP1 reduced its overall affinity
for CDC42 and RAC1, indicating that CT either acts directly as
an additional CDC42 and RAC1 binding domain or may indi-
rectly stabilize RGCT and/or GRD binding to CDC42 and
RAC1.
To examine a direct interaction of IQGAP1 CT, encompass-
ing the C-terminal 99 amino acids (Fig. 1), we used the RHO
proteins and isolated the CT domain as a GST fusion protein
andmeasured their interaction using fluorescence polarization.
The data revealed that CTs have a binding capacity of its own
for CDC42, RAC1, and RHOA that is rather very low (supple-
mental Fig. S5). In addition to RGCT andGRD, CTmay play, as
a very low affinity binder, a direct role in the CDC42 and RAC1
interaction. CT also seems to bind RHOA, which probablymeans
that its binding regionon the surface of these prominentmembers
of the RHO family must be conserved (see “Discussion”).
From the two reported phosphorylation sites (32), Ser-1443
turned out to be critical for the IQGAP1 interaction with
CDC42 andRAC1 but not Ser-1441 (Fig. 4). Kinetic data shown
in Fig. 5C, supplemental Figs. S3 and S4 clearly revealed that
Ser-1443 substitution for Glu more strongly affected the
GRD1-RGCT association with CDC42 and also RAC1 as com-
pared with the dissociation reaction. The rate constants
obtained for GRD1-RGCTS1441E were as the wild-type (WT)
(Fig. 5C). Thus, we propose that RGCT is critical for IQGAP1
associationwith CDC42 and RAC1, which ismodulated by Ser-
1443 phosphorylation, whereas GRD and probably CT may
control the resident time and the off-rate of the protein
complex.
Q61L Mutation Generates a Very High Affinity of CDC42 for
IQGAP1—Two different laboratories reported a high affinity
for the interaction of GRD with CDC42 (25, 31), which clearly
contrasts with our data on very low affinity binding (Fig. 3;
Table 1). An obvious reason for this discrepancy is thatOwen et
al. (25) and LeCour et al. (31) use a constitutive active variant of
CDC42,CDC42Q61L, andweusedCDC42WT.Contrary to these
groups, we did not observe any significant interaction of RAC1
withGRD, and theKd values we obtained for CDC42were up to
300-fold lower (Table 1). To evaluate this discrepancy, we gen-
erated and purified CDC42Q61L and measured its interaction
FIGURE 4. IQGAP1 variants significantly differ in their interaction propertieswith CDC42 andRAC1. A and B, association of different GRD1-RGCT variants
and CT (2 M, respectively) with mGppNHp-RAC1/CDC42 (0.2 M) was measured. A, association of GRD1-RGCTWT (black), GRD1-RGCTS1441E (green), and
GRD1-RGCTS1443E (red), but not with CT (blue), with RAC1-mGppNHp. B, the kobs values, shown as bars, comparatively illustrate association rates of GRD1-CT,
GRD1-RGCTWT, and GRD1-RGCTS1441E with mGppNHp-bound forms of CDC42 and RAC1, which is significantly reduced in the case of GRD1-RGCTS1443E and
completely absent in the case of GRD1, GRD2, and CT under these experimental conditions. C–E, fluorescence polarization experiments were conducted to
measure the interactionofmGppNHp-bound formsofRAC1 (C) andCDC42 (D)with increasingconcentrationsofGRD1-RGCTvariants (WT, S1441E, andS1443E;
0–36 M, respectively). E, calculated Kd values, shown as bars, reveal a significant decrease in the binding affinities of GRD1-RGCT
S1443E as compared with
GRD1-RGCTWT andGRD1-RGCTS1441E. Data are expressed as themean S.D. All kobsmeasurementswere performed in triplicate, and fluorescencepolarization
experiments were conducted in duplicate.
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with GRD1-CT and GRD2 using both stopped-flow and fluo-
rescence polarization. Similar to CDC42WT, no association was
observed for GRD2 and CDC42Q61L (data not shown), but
kinetic measurements revealed a 7-fold stronger interaction of
GRD1-CT with CDC42Q61L with a Kd of 50 nM (Fig. 6, A and B;
Table 1). Equilibrium measurement using fluorescence polar-
ization exhibited amuch stronger interaction of GRD1-CT and
GRD2 with CDC42Q61L as compared with CDC42WT (Fig. 6,
C–F; Table 1). Our analyses clearly demonstrate that substitu-
tion of Gln-61 by Leu engaged binding of effector domains. An
analysis of the GRD-CDC42Q61L structure (31) showed that
Leu-61 is indeed in direct contact withGRD in all four interact-
ing interfaces (data not shown). Collectively, we recapitulate
that CDC42Q61L is not a perfect analog of CDC42WT-GTP
especially in the study of the downstream effectors.
Discussion
Association of downstream effectors with their specific small
GTPases has been generally accepted to release them from an
autoinhibited state, resulting in their activation. The switch
regions of small GTPases have been previously proposed as the
first binding site for the downstream effectors. When this first
contact is achieved, then additional contacts outside the switch
regions are required to achieve effector activation (2). The
molecularmechanismof this process, which is critical for signal
transduction, is unclear for most effectors, especially for scaf-
FIGURE 5.Phosphomimeticmutationof RGCTanddeletionof CT affect the IQGAP1associationwithCDC42andRAC1.A and B, individual rate constants
for theGRD1-CT interactionwith RAC1 andCDC42 are represented inA and B. Left panel, association ofmGppNHp-boundRAC1or CDC42 (0.2M, respectively)
with increasing concentrations of GRD1-CT (2 to 12M).Middle panel, evaluated association rate constant (kon) from the plot of the kobs values, obtained from
the exponential fits to the association data in the left panel against the corresponding concentrations of the GRD1-CT. Right panel, evaluated dissociation rate
constant (koff) measured by the displacement of the GRD1-CT (2 M) from its complex with mGppNHp-bound RAC1 or CDC42 (0.2 M, respectively) in the
presence of excess amounts of non-fluorescent RAC1-GppNHp (10 M). Other kinetics are given in supplemental Figs. S1 and S2. C, calculated individual rate
constants for the interaction of the IQGAP1 variants with RAC1 and CDC42, respectively, plotted as bar charts. Dissociation constants (Kd) were obtained from
the ratio koff/kon. Data are expressed as the mean S.D. All kobs measurements experiments were accomplished in triplicate.
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folding proteins. A straight-forward example isWASP,which is
able to activate the actin-related proteins ARP2/3 if its C-ter-
minal ARP2/3-binding domains are unmasked upon associa-
tion with CDC42 (10). This process controls assembly of actin
filaments (37). In contrast, IQGAP1 is a multifaceted protein
that employs different domains in an assembly of multitude
protein complexes, coordinating different processes in a variety
of cell types (14–17).
A key role has been previously assigned to the IQGAP1 GRD
association with the switch regions of CDC42 and RAC1 (25,
26), and this has been generally accepted as an interaction
model for these proteins, albeit with suggestions that critical
determinants for RAC1 binding to IQGAP1 lie outside this
region (25). Very recently, the crystal structure of GRD-
CDC42Q61L complex has been published (31). It consists of four
CDC42Q61L molecules binding to a dimeric GRD. An inspec-
tion of this structure revealed that all four contact sites engage
the switch regions of CDC42Q61L (data not shown). However,
our kinetic and equilibriummeasurements conductedwith var-
ious deletion and point mutations of IQGAP1, and the use of
two different fluorescence reporter groups clearly exclude a
central role for GRD in the recognition of RHO proteins via
their switch regions. Thus, we propose a binding of GRD adja-
cent to or outside the switch regions of CDC42. Instead, a
region next to GRD appeared as the central domain for the
association of IQGAP1 with the switch regions of both CDC42
and RAC1. Mimetic mutations of the PKC phosphorylation
site Ser-1443 in this domain significantly affected IQGAP1
association with CDC42 and RAC1. In contrast to CDC42 and
RAC1 and unlike previous cell-based studies (38, 39) but very
much in line with early studies (33, 40–45), no physical inter-
action of neither GRD2 orGRD1-CTwas observedwith RHOA
using both kinetic and equilibriummeasurements (Figs. 2C and
3, B and C). This clearly indicates that the observed IQGAP1
associationwith RHOA is indirectlymediated by other proteins
in co-immunoprecipitates. Interaction of GRD1-CT with
CDC42 and RAC1 is strong and GTP-dependent. GRDmade a
considerable contribution to an overall binding affinity of
IQGAP1 to CDC42 and RAC1, although its role in these inter-
actions turned out to be rather different (Fig. 3). GRD under-
went a very weak interaction with mGDP-bound, inactive
CDC42 but not with RAC1-mGDP. This rather suggests that
GRD binds to a surface outside the switch regions of CDC42,
which is obviously not conserved in RAC1. Furthermore, our
data also demonstrate that the extreme C-terminal region of
IQGAP1, CT (99 aa), may also bind, although with a very low
affinity, to a common site of CDC42 and RAC1 that is also
shared by RHOA (supplemental Fig. S5).
Previous studies by other groups have shown that shorter
IQGAP1 fragments, encompassing the GRD domain, are
responsible for the CDC42 and RAC1 interactions. Zhang and
coworkers showed that an activated form of CDC42 is able to
bind IQGAP1GRD1-CT (aa 864–1657) (76). One year later the
same group reported that not only CDC42 but also RAC1,
although with lower affinity, could interact to GRD1-CT (23).
Afterward, Nomanbhoy and Cerione (47) have shown that
GRD1-CT interacts tightlywithCDC42-mGTPusing a fluores-
cence assay. Owen et al. (25) have also reported that a GRD
protein (aa 950–1407) was able to tightly bindCDC42Q61Lwith
a Kd value of 140 nM but failed to bind RAC1(Q61L) using a
FIGURE6.Q61Lmutationgreatly increasedCDC42affinity for IQGAP1.A, individual rate constants for theGRD1-CT interactionwithCDC42Q61L. Association
of tGppNHp-bound CDC42Q61L (0.2 M) with increasing concentrations of GRD1-CT (2 to 10 M) is shown in the left panel. Themiddle panel shows evaluated
association rate constant (kon), and the right panel shows the evaluated dissociation rate constant (koff) measured by the displacement of the GRD1-CT (2M)
from its complex with tGppNHp-bound CDC42 (0.2 M) in the presence of excess amounts of non-fluorescent CDC42Q61L-GppNHp (10 M). B, calculated
individual rate constants for the interactionof theGRD1-CTwithCDC42Q61L, plotted asbar charts. A dissociation constant (Kd) of 0.05Mwasobtained from the
ratio koff/kon.C–F, fluorescence polarizationwere performedby titrating CDC42
Q61L-tGppNHp (1M)with increasing concentrations of GRD1-CT (0–2.5M) (C)
and GRD2 (0–7.5 M) (D) or CDC42Q61L-mGppNHp with increasing concentrations of GRD1-CT (0–3 M) (E) and GRD2 (0–7.5 M) (F).
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scintillation proximity assay. In contrast, GRD1-CT has shown
a much higher affinity for the Q61Lmutant of not only CDC42
but also of RAC1, and yet the GRD was proposed to be the
binding domain of IQGAP1 that associates with the switch
regions of CDC42. Correspondingly, Kurella et al. (26) reported
that GRD2 (aa 962–1345) binds CDC42Q61L in a GTP-depen-
dent manner with an affinity of 1.3 M using isothermal titra-
tion calorimetry. These biochemical data (summarized inTable
1) along with the homology modeling based on the RAS-RAS-
GAP structure (29) provided a first structural model of
IQGAP1 GRD contacting the switch regions of the CDC42,
which is generally accepted in the community (24–26, 30, 48).
A very recent study from the same laboratory has determined
the crystal structure of GRD with CDC42Q61L (31), which is
very similar to their previous model (26). On the contrary, we
observed different properties of GRD1-CT and GRD2 in their
interactions with CDC42WT. This was evidenced by kinetic
measurements of GRD1-CT andGRD1-RGCT association, but
not GRD, with CDC42 and RAC1 proteins (Figs. 2 and 4; no
changes in fluorescence were observed withGRD). Similar data
were obtained by using tamra, a different fluorescence reporter
instead ofmant. Equilibriummeasurements using fluorescence
polarization not only substantiated the essential role of
IQGAP1 RGCT in a GTP-dependent interaction with CDC42
and RAC1, in agreement with our kinetic analysis, but also pro-
vided striking insights into the main feature of IQGAP1 GRD.
Our quantitative analysis under equilibrium conditions clearly
revealed that GRD undergoes a low-affinity interaction with
CDC42, but its binding in contrast to RGCT is partially
nucleotide-dependent.
mGDP-bound RHOA and particularly RAC1 did, however,
not reveal any interaction with IQGAP1 GRD. A faster kon, a
slower koff, and a lower Kd of GRD1-CT for CDC42, in direct
comparison to RAC1, strongly support our data from fluores-
cence polarization and demonstrated that not only RGCT but
also GRD bind mGppNHp-bound CDC42 and RAC1 (Fig. 3).
The significance of RGCT as a GTP-dependent interacting
domain for CDC42 and RAC1 was proved using a single point
mutant of GRD1-RGCT (Ser-1443 substituted by Glu), which
led to the abolition of a GTP-dependent interaction of GRD1-
RGCT, whereas nucleotide-independent association with
CDC42 through GRD was unchanged. Ser-1443 was identified
as the major site phosphorylated on IQGAP1 in intact cells
treated with PMA (phorbol 12-myristate 13-acetate) (32).
Phosphomimetic mutation of Ser-1441, a second phosphoryla-
tion site, that was shown to be phosphorylated to a lesser extent
as compared with Ser-1443 (32), did not affect the interaction
with either CDC42 or RAC1. Grohmanova et al. (33) previously
showed via GST pulldown experiments and usingMCF10A cell
lysate that in the presence of phosphatase inhibitor there is a
significant reduction in the interaction between IQGAP1 and
CDC42-GTP in contrast to nucleotide-depleted CDC42, which
binds to phosphorylated IQGAP1muchmore strongly. In addi-
tion, our data have clearly demonstrated that the region
upstream of GRD2 (aa 863–961) is dispensable for the CDC42
and RAC1 interaction.
Another interesting issue was a significantly faster dissocia-
tion ofGRD1-RGCT (lacking theCTdomain) fromCDC42 and
RAC1 as compared with GRD1-CT. This clearly indicates an
involvement of the very C-terminal 99 amino acids (CT) in the
overall binding affinity of GRD1-CT for CDC42 andRAC1 (Fig.
5C). Our fluorescence polarization measurements showed that
isolated CT has the tendency to associate with CDC42, RAC1,
and also RHOA although with low affinity (supplemental Fig. S5).
A Multiple-step Binding Mechanism—Kinetic and equilib-
riummeasurements conducted in this study challenge the par-
adigm that the ability of IQGAP1 to interact with RAC/CDC42
proteins is mainly attributed to its GRD. We propose that
GRD1-CT, the C-terminal 795 amino acids of IQGAP1,
encompasses at least 3 distinct domains that may differently
interact with CDC42 and RAC1 at different contact sites in a
multistep manner. The switch regions of the RHO family pro-
teins are the first binding site for the downstream effectors.
Once it is occupied, additional contacts outside the switch
regions are required to guarantee effector activation (2, 10).
Accordingly, RGCT appears as a central domain that rapidly
associates with the switch regions of GTP-bound CDC42 and
RAC1 but not RHOA. CT may additionally bind to a different
site conserved in RAC1 and CDC42 and extend the residence
time of the respective complexes. A possible interaction of CT
with RHOA seems to be physiologically irrelevant simply
because RGCT and GRD do not recognize RHOA, at least not
under experimental conditions in this study. These interactions
may induce a local conformational change enabling GRD to
bind selectively to GTP-bound CDC42 and RAC1 but not
RHOA. Such sequential but differential association of IQGAP1
with CDC42 versus RAC1 can be envisaged as conformational
changes within IQGAP1, enabling a set of interactions at struc-
turally accessible and available regionswith its downstream tar-
gets depending on the upstream signals and the cell fate. The
fact that GDP-bound CDC42, but not RAC1, is able to interact
with GRD suggests that GRD may undergo a low affinity com-
plex with GDP-bound, inactive CDC42 proteins outside or
adjacent to its switch regions in a way that is independent of the
upstream signals, providing GRD is structurally accessible and
available for interactions. This may also be a model for the
IQGAP1-mediated scaffolding of the CDC42-GTP-WASP
complex regulating actin assembly, extension of lamellipodia,
and promotion of dendritic spine head formation (15, 49, 50).
Concluding Remarks—Protein-protein interaction studies on
the active,GTP-bound formofCDC42 andRAC1has identified
IQGAP1 as a downstream effector (22–26, 30, 34, 51–54).
Accumulating evidence supports diverse roles for the IQGAP1
interaction with CDC42 and RAC1 in vertebrates, which has
significance for a variety of biological functions. However, the
nature of such protein-protein recognition processes has
remained obscure. Initially it was thought that modulation of
the cytoskeletal architecture is the primary function of the
interaction of IQGAP1 with RHO proteins, but it is now clear
that it hasmany critical physiological roles beyond the cytoskel-
eton. However, the consequences of different interactions of
IQGAP1 with CDC42 versus RAC1 remained to be addressed.
Lack of GRD interaction with RAC1may be compensated by
calmodulin as an accessory protein, which has been reported as
binding partner of RAC1 and IQGAP1 (55–57). The ability of
GRD in binding outside the switch regions of CDC42may facil-
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itate the scaffolding function of IQGAP1 in localizing CDC42
and WASP at specific sites.
It is also of major interest to address the question of whether
the C-terminal domains RGCT and CT compete in binding to
CDC42 and RAC1 with other proteins, including CLIP-170,
E-cadherin, -catenin, adenomatous polyposis coli (APC),
mDIA, CLASP2, TSG101, SEC3/8, and SMG9. These proteins
have also been reported to associatewith RGCTandCT (15, 41,
58–63). Adenomatous polyposis coli has been shown to acti-
vate ASEF, a CDC42-specific Dbl protein (64), at the leading
edge of a migrating cell, which may thereby initiate CDC42-
IQGAP1 signaling.
There is one obvious consequence of IQGAP1 as a RAC1/
CDC42 effector; IQGAP1 not only has direct interactions with
the small GTPases but also has been detected in a complex with
an effector (PAK6) and a regulator (TIAM1) of small G proteins
(65). Immunoprecipitation of IQGAP1 fromhumanpulmonary
artery endothelial cells isolated a complex containing TIAM1,
RAC1, Src, cortactin, p47phox, and phospholipase D2 (65) but
the direct interaction of TIAM1 and IQGAP1 has not been
reported yet, and the possible biological relevance of the inter-
action remains unknown.
Subcellular localization of RHO GTPases to cellular mem-
branes is known to be critical for their biological activity. This is
achieved by a hypervariable region (HVR) (66) and a lipid
anchor in their C-terminal tail at a distinct cysteine residue in
the CAAX motif (C is cysteine, A is any aliphatic amino acid,
and X is any amino acid) (67). RHOGDI is known to dislodge
RHO proteins from the plasma membrane (68). As IQGAP1
also binds RHOGDI (20), it would be interesting to know
whether IQGAP1 is a displacement factor for the RHOGDI
complex with RAC1 or CDC42.
Another issue is the intramolecular autoregulation and auto-
inhibitory of IQGAP1 by its domains. Based on our structural
modeling, we hypothesize that the calponin homology domain
may act as an autoinhibitory domain that must be released in
the course of IQGAP1 activation.Wehypothesize that two pro-
teins thatmay release IQGAP1 from its autoinhibited statemay
in fact be RAC1-GTP and calmodulin. The interaction of cal-
modulin with RAC1 (69) and IQGAP1 (45) has been reported,
but the role of calmodulin in enhancing the RAC1-mediated
IQGAP1 activation is not investigated yet. Another significant
question to be answered is the possible role of these interac-
tions in carcinogenesis. Published results suggest that blocking
IQGAP1-CDC42 and IQGAP1-RAC1 complex formation will
decrease the amount of active forms of CDC42 and RAC1 in
carcinoma cells and thus reduce tumorigenesis. Therefore,
antagonists that disrupt the binding of IQGAP1 to RAC1 and/
or CDC42 could prevent tumor invasion, proliferation, and
migration and could act as specific chemotherapeutic agents.
However, the design of such antagonists absolutely and criti-
cally requires knowledge of the key protein-protein interfaces
between IQGAP1 and these small GTPases. The data reported
here provide an important step in defining these sites.
Experimental Procedures
Constructs—Coding sequences for RHO proteins and
IQGAP1 variants were amplified using sequence-specific
primer and cloned into the expression vector. Different pGEX
vectors encoding an N-terminal glutathione S-transferase
(GST) fusion protein were used for the overexpression of
various human genes: different IQGAP1 (accession number
P46940) regions (aa 863–1345, 863–1657, 877–1558, 1276–
1657, 1276–1575, 1576–1657) and also C-terminal truncated
RAC1 (aa 1–179), CDC42 (aa 1–178), and RHOA (aa 1–181).
pMCSG7 vector was used for overexpression of IQGAP1 aa
962–1345 and pET46 EkLIC vector (Merck) for the overexpres-
sion of IGQAP1 S1441E and S1143E mutants (aa 877–1558) as
His-tagged proteins. The Kazusa cDNA clone KIAA0051 (70)
was used as a template for site-directed mutagenesis.
Proteins—All proteins were purified according to the proto-
cols described (3, 71, 72). Briefly, Escherichia coli strains pLysS
BL21(DE3), CodonPlusRIL, or BL21(Rosetta) were trans-
formed and used to purify the respective protein. Protein
extraction was carried out by incubating cells at 4 °C with
DNase I (10 g ml1) and lysozyme (10 g ml1) followed by
cell lysis using a microfluidizer (model M110S, Microfluidics
Corp.). Bacterial lysateswere centrifuged to collect soluble frac-
tions, and tagged proteins were isolated from the supernatant
via Ni-NTA orGST affinity purification. If needed, the GST tag
was cleaved with tobacco etch virus protease (4 units mg1,
4 °C, overnight), and proteins were subjected to gel filtration
using a standard buffer containing 30mMTris-HCl, pH 7.5, 150
mM NaCl, 5 mM MgCl2, and 3 mM DTT. All purified proteins
were analyzed by SDS-PAGE (Fig. 1) and stored as either tag-
fused or cleaved protein at80 °C.
Nucleotide-free RHO proteins were prepared using alkaline
phosphatase (Roche Applied Science) and phosphodiesterase
(Sigma) at 4 °C as described (73). Various fluorescence reporter
groups, including mant and tamra, have been coupled to 2
(3)-hydroxyl group of the ribose moiety of GDP and GppNHp
via ethylenediamine (EDA) to obtain fluorescent nucleotide
(Jena Bioscience).
Stopped-flow Fluorescence Measurements—Kinetics measure-
ments were monitored by stopped-flow apparatus (Hi-Tech
Scientific SF-61 with a mercury xenon light source and TgK
Scientific Kinetic Studio software) and performed as described
(72). Equal volumes of two different solutions containing
IQGAP1 (different concentrations) or RHO protein (0.2 M)
were rapidly shot into a mixing chamber, and the fluorescence
was directly detected after a dead timeof4ms (Fig. 2B). Buffer
contained 30mMTris-HCl, pH 7.5, 10mMKH2PO4/K2HPO4, 5
mM MgCl2, and 3 mM DTT. For excitation, wavelengths of 546
nm and 360 nm were used for tamra and mant fluorophores,
respectively, and a 570 nm (tamra) and 408 nm (mant) cut-off-
filters (Schott glass) were, respectively, used to collect emitted
light. To obtain high accuracy data, 4–6 measurements were
performed and averaged. The observed rate constants (kobs)
were fitted single exponentially using the GraFit program
(Erithacus software).
Fluorescence Polarization—Experiments were performed in
a Fluoromax 4 fluorimeter in polarization mode as described
(46). Briefly, increasing amounts of different variants of
IQGAP1 were titrated to mGppNHp- and tGppNHp-bound
RHO proteins (1 M) in a buffer containing 30 mM Tris/HCl,
pH 7.5, 150 mM NaCl, 5 mM MgCl2, 3 mM DTT, and a total
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volume of 200 l at 25 °C. For excitation, wavelengths of 546
nm and 360 nm (slit width: 8 m) were used for tamra and
mant fluorophores, respectively, and 579 nm (tamra) and
450 nm (mant) were used for emission (slit width: 10m). To
increase the overall molecular mass of some IQGAP1 domains,
GST fusion proteins were used to get larger increase in the polar-
ization signal upon binding. The dissociation constants (Kd) were
calculated by fitting the concentration-dependent binding curve
using a quadratic ligand binding equation.
Analytical Size Exclusion Chromatography—To show that
the purified proteins are non-aggregating, analytical SEC was
performed using a superdex 200 10/30 column (GE Health-
care). The buffer contained 30 mM Tris/HCl, pH 7.5, 150 mM
NaCl, 5 mMMgCl2, and 3 mM DTT. For molecular mass deter-
mination the column was calibrated with standard proteins of
known molecular mass: ferritin (440 kDa), aldolase (158 kDa),
conalbumin (75 kDa), ovalbumin (43 kDa), carbonic anhydrase
(29 kDa), and ribonuclease A (13.7 kDa). Protein samples (100
M in 200 l buffer) were injected onto the preequilibrated
column, and the flow rate was sustained at 0.5 ml/min.
CD Spectroscopy—Far-UV CD spectra of IQGAP1 protein
samples at protein concentrations ranging from 0.68 to 2.1 M
in 20 mM sodium phosphate buffer, pH 7.2, were recorded on a
Jasco J-815CD spectrometer (Jasco, Gross-Umstadt, Germany)
equipped with a temperature-controlled cell holder running at
20 °C using a quartz cuvette with a 1-mm path length and
instrument settings as follows: 0.2-nm step size, 50-nm min1
scan speed, and 1-nm bandwidth. Signal-to-noise ratio was
improved by accumulation of 10 scans per sample. The mean
residue ellipticity []MRW in degcm2dmol1 was calculated
from the equation []MRW  (obsMRW)/(cd 10), where

obs
is the observed ellipticity (in degrees), c is concentration (in
gml1),d is cell path length (incm), andMRWis themeanresidue
weight, (molecular weight divided by number of peptide bonds).
Secondary structure fractionswere calculated via theDiChroWeb
program package (75) using the CDSSTR program (74)
Statistical Analysis—Data shown in the graphs are the average
of triplicate or duplicate experiments. Data are expressed as the
mean  S.D. All stopped-flow experiments were performed in
triplicate, and polarization experiments were performed in
duplicate.
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